[Medicinal therapy of benign prostate syndrome with phosphodiesterase-5 inhibitors]. [electronic resource]
Producer: 20130826Description: 204-11 p. digitalISSN:- 1433-0563
- Carbolines -- adverse effects
- Controlled Clinical Trials as Topic
- Cyclic GMP -- metabolism
- Cyclic Nucleotide Phosphodiesterases, Type 5 -- metabolism
- Erectile Dysfunction -- drug therapy
- Humans
- Imidazoles -- adverse effects
- Lower Urinary Tract Symptoms -- diagnosis
- Male
- Phosphodiesterase 5 Inhibitors -- adverse effects
- Piperazines -- adverse effects
- Prostatic Hyperplasia -- diagnosis
- Purines -- adverse effects
- Sildenafil Citrate
- Sulfones -- adverse effects
- Tadalafil
- Triazines -- adverse effects
- Urodynamics -- drug effects
- Vardenafil Dihydrochloride
No physical items for this record
Publication Type: Comparative Study; English Abstract; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.